Avant Sciences, Inc. — Form D
Avant Sciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-29. The offering totals $300K, of which $175K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-29
- Form: D
- Accession: 0002009739-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $175K
- Remaining: $125K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2024-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-519935
Issuer
- Name: Avant Sciences, Inc.
- CIK: 0002009739
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 201 E. 86TH STREET, NEW YORK, NY, 10028
- Phone: 650-387-1268
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Avnish Deobhakta | Director | New York, NY |
| Paul Lee | Director | CHICAGO, IL |
| Avnish Deobhakta | Executive Officer | New York, NY |
| Paul Lee | Executive Officer | CHICAGO, IL |
More